Abstract
Given the somewhat unpredictable course of melanoma, it is difficult to assess prognosis, especially for a patient at high risk for disease progression. This study assessed the prognostic value of the presence of circulating melanocytes detected by polymerase chain reaction (PCR) in patients with melanoma. Using probes directed against melanocytes, PCR was performed on serum from patients with different stages of malignant …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
